Prof. Dr. Mesut Çetin Ege Üniversitesi Tıp Fakültesinden mezun olmuştur. Uzmanlığını Ankara GATA’dan almıştır. İstanbul GATA Haydarpaşa Eğitim Hastanesinde 1991 yılında doçent, 1999 yılında da profesör olmuştur. İstanbul GATA Haydarpaşa Eğitim Hastanesi’nin 1996 -2007 yılları arasında Psikiyatri Kliniği direktörlüğü yapmıştır. 2015 yılında emekli olup,daha sonra özel muayenehanesinde çalışmalarını sürdürmektedir.

İlgi alanları genel psikiyatri , psikofarmakoloji, hipnoz ve özellikle kognitif hipnoterapi, bilişsel davranışçı terapi, kişilerarası ilişkiler psikoterapileridir.

Katıldığı Kongreler,

10.Uluslararası Psikofarmakoloji Kongresi (25-29 Nisan 2018)
9. Uluslararası Psikofarmakoloji Kongresi (26-30 Nisan 2017)
8. Uluslararası Psikofarmakoloji Kongresi (20-24 Nisan 2016)
7. Uluslararası Psikofarmakoloji Kongresi (15-19 Nisan 2015)
6. Uluslararası Psikofarmakoloji Kongresi (16-20 Nisan 2014)
5. Uluslararası Psikofarmakoloji Kongresi (30 Ekim-03 Kasım 2013)
Psikofarmakoloji Tedavi Güncellemesi 2012 (15-18 Kasım 2012)
4. Uluslararası Psikofarmakoloji Kongresi (23-27 Kasım 2011)
Psikofarmakoloji Tedavi Güncellemesi 2010 (11-14 Mart 2010)
4. Uluslararası Psikofarmakoloji Kongresi (12-15 Mart 2009)
Psikofarmakoloji Tedavi Güncellemesi 2008 (29-31 Ocak 2008)
2. Uluslararası Psikofarmakoloji Kongresi (22-24 Haziran 2007)
1. Uluslararası Psikofarmakoloji Kongresi (14-17 Aralık 2005)

Prof.Dr Mesut Çetin’in Yayınları:

Basoglu C, Cetin M, Semiz UB, Agargun MY, Ebrinc S. Premenstrual exacerbation and suicidal behavior in patients with panic disorder. Compr Psychiatry 2000;41:103-105.
Cetin M, Turgay A. Antipsychotic Treatment In The Fiftieth Year Of Modern Psychopharmacology: An Update. Klinik Psikofarmakoloji Bulteni – Bulletin of Clinical Psychopharmacology 2002;12(4):211-226

Cetin M, Kose Samet, Ebrinc S, Kistak A. The assessment of the efficacy of the psychotropic drugs. Klinik Psikofarmakoloji Bulteni – Bulletin of Clinical Psychopharmacology 2002;12:159-164

Ebrinc S, Basoglu C, Cetin M, Filiz M, Sendogan N. The efficacy and safety of haloperidol and risperidone in patients with schizophrenia. Klinik Psikofarmakoloji Bulteni – Bulletin of Clinical Psychopharmacology 2002;12(1):6-13
Gultepe M, Ozcan O, Avsar K, Cetin M, Ozdemir AS, Gok M. Urine methylmalonic acid measurements for assessment of cobalamin deficiency related to neuropsychiatric disorders. Clin Biochem 2003;36:275-282.

Cetin M, Ebrinc S, Basoglu C, Semiz UB, Cobanoglu N, Can S, Karaduman F. Factors affecting the satisfaction of recruits with the military environment.Turk Psikiyatri Derg. 2003 Summer;14(2):125-33.
Ebrinc S, Cetin M, Oner O. Atypical antipsychotics in treatment of bipolar disorder in special populations. Klinik Psikofarmakoloji Bulteni – Bulletin of Clinical Psychopharmacology 2004;(14):236-250.
Semiz UB, Turhan V, Basoglu C, Oner O, Ebrinc S, Cetin M. Leptospirosis presenting with mania and psychosis: four consecutive cases seen in a military hospital in Turkey. Int J Psychiatr Med 2005;35:299-305.

Semiz UB, Basoglu C, Cetin M, Ebrinc S. Panic disorder due to ingestion of single dose ecstasy. Int J Psychiatr Clin Pract 2005; 9: 138-141.
Cetin M, Kose S. Identification and posttraumatic stres disorder symptoms in recue workers in Marmara, Turkey, earthquake. J Traumatic Stress 2005;18:485-489.

Semiz UB, Ates MA, Algul A, Iyisoy MS, Gunes C, Basoglu C, Cetin M. The prevalence of substance use disorder in male subjects with antisocial personality disorder. Klinik Psikofarmakoloji Bulteni – Bulletin of Clinical Psychopharmacology 2007;(17):162–166.

Dilbaz N, Karamustafaliolu O, Oral T, Onder E, Cetin M. Evaluation of compliance to treatment and factors affecting compliance for schizophrenia outpatients Klinik Psikofarmakoloji Bulteni – Bulletin of Clinical Psychopharmacology 2006;16(4):223-232.
Semiz UB, Basoglu C, Ebrinc S, Cetin M. Childhood trauma history and dissociative experiences among Turkish men diagnosed with antisocial personality disorder.Soc Psychiatry Psychiatr Epidemiol. 2007 Nov;42(11):865-73.

Semiz UB, Cetin M, Basoglu C, Ebrinc S, Uzun O, Balibey H, Algul A, Ates A. Clinical predictors of therapeutic response to clozapine in a sample of Turkish patients with treatment-resistant schizophrenia.Prog Neuropsychopharmacol Biol Psychiatry. 2007 Aug 15;31(6):1330-6.
Semiz UB, Basoglu C, Oner O, Munir KM, Ates A, Algul A, Ebrinc S, Cetin M. Effects of diagnostic comorbidity and dimensional symptoms of attention-deficit-hyperactivity disorder in men with antisocial personality disorder. Aust N Z J Psychiatry. 2008 May;42(5):405-13.

Semiz UB, Algul A, Basoglu C, Ates MA, Ebrinc S, Cetin M, Gunes C, Gunay H. The relationship between subjective sleep quality and aggression in male subjects with antisocial personality disorder. Turk Psikiyatri Derg. 2008 Winter;19(4):373-81.
Cetin M, Antidepressants, antipsychotics: Reliability of metaanalyses. Klinik Psikofarmakoloji Bulteni–Bulletin of Clinical Psychopharmacology, 2008:18(4):245-250(in Turkish).
Ebrinc S, Semiz UB, Basoglu C, Cetin M, Agargun MY, Algul A, Ates A. Self-mutilating behavior in patients with dissociative disorders: the role of innate hypnotic capacity. Isr J Psychiatry Relat Sci. 2008;45(1):39-48.
Cetin M, Antidepressants, antipsychotics: Reliability of metaanalyses. Klinik Psikofarmakoloji Bulteni–Bulletin of Clinical Psychopharmacology, 2008:18(4):245-250(in Turkish).

Semiz UB, Basoglu C, Ebrinc S, Cetin M. Nightmare disorder, dream anxiety, and subjective sleep quality in patients with borderline personality disorder. Psychiatry Clin Neurosci. 2008 Feb;62(1):48-55.
Semiz UB, Basoglu C, Oner O, Munir KM, Ates A, Algul A, Ebrinc S, Cetin M. Effects of diagnostic comorbidity and dimensional symptoms of attention-deficit-hyperactivity disorder in men with antisocial personality disorder. Aust N Z J Psychiatry. 2008 May;42(5):405-13.

Semiz UB, Algul A, Basoglu C, Ates MA, Ebrinc S, Cetin M, Gunes C, Gunay H. The relationship between subjective sleep quality and aggression in male subjects with antisocial personality disorder. Turk Psikiyatri Derg. 2008 Winter;19(4):373-81.
Basoglu C, M. Ates A, Algul A, Ipcioglu M, Gecici O, Yilmaz O, Semiz UB, S Ebrinc S Gulsun M, Ozcan O, Kilic S, Cetin M. Adjuvant folate with escitalopram treatment and homocystein, folate, vitamin B-12 levels in patients with major depressive disorder Klinik Psikofarmakoloji Bulteni – Bulletin of Clinical Psychopharmacology 2009;19(2):135-142.

Algul A, Ates MA, Semiz UB, Basoglu C, Ebrinc S, Gecici O, Gülsün M, Kardesoglu E, Cetin M. Evaluation of general psychopathology, subjective sleep quality, and health-related quality of life in patients with obesity. Int J Psychiatry Med. 2009;39(3):297-312.
Algul A, Sen H, M Ates, Yen T, Durmaz O, Ozkan S, Basoglu C, Semiz UB, Ebrinc S, Daglı G, Cetin M. “ElektrokonvUlzif tedavide propofol ile propofol remifentanil kombinasyonun nobet suresi ve hemodinami Uzerine etkisi”, Klinik Psikofarmakoloji Bulteni, Bulletin of Clinical Psychopharmacology 2009;19:24-28(in Turkish).

Basoglu C, M. Ates A, Algul A, Ipcioglu M, Gecici O, Yilmaz O, Semiz UB, S Ebrinc S Gulsun M, Ozcan O, Kilic S, Cetin M. Adjuvant folate with escitalopram treatment and homocystein, folate, vitamin B-12 levels in patients with major depressive disorder Klinik Psikofarmakoloji Bulteni – Bulletin of Clinical Psychopharmacology 2009;19(2):135-142.

Algul A, Ates MA, Semiz UB, Basoglu C, Ebrinc S, Gecici O, Gülsün M, Kardesoglu E, Cetin M. Evaluation of general psychopathology, subjective sleep quality, and health-related quality of life in patients with obesity. Int J Psychiatry Med. 2009;39(3):297-312.

Cetin M, Aricioglu F, Pharmacovigilance and its significance in psychopharmacology,Klinik Psikofarmakoloji Bulteni – Bulletin of Clinical Psychopharmacology, 2009;19(4):335-339(in Turkish).

Cetin M, Aricioglu F. On the debate of original drug versus generic drug. Klinik Psikofarmakoloji Bulteni – Bulletin of Clinical Psychopharmacology, 2009;19(3):211-213(in Turkish).

Cetin M, Acikel C. In perspective of meta-analyses: Are all of the antidepressants similar? Klinik Psikofarmakoloji Bulteni – Bulletin of Clinical Psychopharmacology, 2009;19(2):87-92(in Turkish).

Cetin M, Kilic S. How to comprehend the recent meta-analyses conducted on typical and atypical antipsychotics?Klinik Psikofarmakoloji Bulteni –Bulletin of Clinical Psychopharmacology, 2009;19(1):1-4(in Turkish).

Basoglu C, Cetin M, Oner O, Ebrinc S, Semiz UB, Kandilcioglu H, Silit E, Kizilkaya E. Comparison of right thalamus and temporal cortex metabolite levels of drug-naive first-episode psychotic and chronic schizophrenia in patients. Turk Psikiyatri Derg.2006 Summer;17(2):85-91.

Barlas IO, Cetin M, Erdal ME, Semiz UB, Basoglu C, Ay ME, Herken H, Uzun O. Lack of association between DRD3 gene polymorphism and response to clozapine in Turkish schizoprenia patients. Am J Med Genet B Neuropsychiatr Genet. 2009 Jan 5;150B(1):56-60.

Atefl MA, Algul A, Semiz UB, Gunefl C, Cetin M.Amisulpiride Usage In Treatment-Resistant Tourette’s Syndrome: A Case Report. New/Yeni Symposium Journal 2009;47(1):16-18

Algul A, Sen H, Ates MA, Yen T, Durmaz O, Ozkan S, Basoglu C, U. Semiz B, Ebrinc S, Dagli G, Cetin M. Propofol versus propofolremifentanil combination anaesthesia in electroconvulsive therapy: Effects on seizure duration and hemodynamics. Klinik Psikofarmakoloji Bulteni – Bulletin of Clinical Psychopharmacology 2009;19(1):29-38.

Algul A, Gulsun M, Ates A, Ayata A, Basoglu C, Ebrinc S, Semiz UB, Ersanli D, Cetin M. Temperament and character in patients with central serous chorioretinopathy. Anatolian Journal of Clinical Investigation, 2009;(3):40-43.

Cetin M. Escitalopram in treatment of fibromyalgia: A pilot study International Journal Of Neuropsychopharmacology 2010;13:72.

Cetin M, Aricioglu F. Pharmacoeconomics and its importance in psychiatry. Klinik Psikofarmakoloji Bulteni –Bulletin of Clinical Psychopharmacology, 2010;20(1):1-4(in Turkish).

MacKay M, Cetin M, Baker G, Dursun S. Modulation of central nitric oxide as a therapeutic strategy for schizophrenia. Klinik Psikofarmakoloji Bulteni –Bulletin of Clinical Psychopharmacology, 2010;20(2):115-119.

Basoglu C, Oner O, Ates AM, Algul A, Semiz UB, Ebrinc S, Cetin M, Ozcan O, Ipcioglu OM. Association between symptom improvement and change of body mass index, lipid profile, and leptin, ghrelin, and cholecystokinin levels during 6-week olanzapine treatment in patients with first-episode psychosis. J Clin Psychopharmacol. 2010 Oct;30(5):636-8.

Cetin M. The place of atypical antipsychotics in the treatment- resistant depressions Klinik Psikofarmakoloji Bulteni-Bulletin of Clinical Psychopharmacology 2010;20(Suppl. 1):S15-S25.

Dursun S, Hallak J, Devarajan S, Baker G, Cetin M. High-dose antipsychotic medication; a practical pocket checklist. Klinik Psikofarmakoloji Bulteni, Bulletin of Clinical Psychopharmacology 2010;20:187-188.

Aricioglu F, Cetin M. Personalized drug therapy in psychiatry: Maybe a little old or a little new, but the treatment of future. Klinik Psikofarmakoloji Bulteni, Bulletin of Clinical Psychopharmacology 2010;20:269-271(in Turkish).

Basoglu C, Oner O, Gunes C, Semiz UB, Ates AM, Algul A, Ebrinc S, Cetin M, Ozcan O, Ipcioglu O. Plasma orexin A, ghrelin, cholecystokinin, visfatin, leptin and agouti-related protein levels during 6-week olanzapine treatment in first-episode male patients with psychosis. Int Clin Psychopharmacol. 2010 May;25(3):165-71.
Alpay Ates M, Algul A, Semiz UB, Gecici O, Basoglu C, Ebrinc S, Cetin M. Clinical characteristics of self-mutilating behavior in Turkish male subjects with antisocial personality disorder: relationship to psychopathy. Int J Soc Psychiatry. 2011 May;57(3):237-47.

Basoglu C, Oner O, Ates A, Algul A, Bez Y, Ebrinc S, Cetin M. Temperament traits and psychopathy in a group of patients with antisocial personality disorder. Compr Psychiatry. 2011 Mar 10.

Karolewicz B, Cetin M, Aricioglu F. Beyond the glutamate N-methyl D-aspartate receptor in major depressive disorder: the mTOR signaling pathway. Bulletin of Clinical Psychopharmacology 2011;21:1-6.

Balibey H, Basoglu C, Lundgren S, Babaoglu MO, Yasar U, Herken H, Rane A, Bozkurt A, Cetin M. CYP1A2*1F polymorphism decreases clinical response to clozapine in patients with schizophrenia. Klinik Psikofarmakoloji Bülteni- Bulletin of Clinical Psychopharmacology 2011;21(2):93-9.

Basoglu C, Oner O, Ates A, Algul A, Bez Y, Cetin M, Herken H, Erdal ME, Munir KM. Synaptosomal-associated protein 25 gene polymorphisms and antisocial personality disorder: association with temperament and psychopathy.Can J Psychiatry. 2011 Jun;56(6):341-7.

Cetin M. Psychotropic Drug Use in Pregnancy: An Update. Psikofarmakoloji Bulteni – Bulletin of Clinical Psychopharmacology 2011;21(2):161-73.

Cetin M, Gumru S, Feyza Aricioglu F. Nanotechnology applications in neuroscience:advances, opportunities and challenges. Bulletin of Clinical Psychopharmacology 2012;22(2):115-20.

Cetin M, Aricioglu A, Acikel CH, Kilic S. Today’s psychopharmacological treatments: results, problems, new perspectives. Bulletin of Clinical Psychopharmacology 2012;22(2):198-204.

Dalkilic A, Cetin M. Editorial: past, present and future psychiatric trends in USA: lessons for all. Klinik Psikofarmakoloji Bulteni-Bulletin of Clinical Psychopharmacology 2012;22(3):205-9.

Cetin M. Asenapine: A novel hope in the treatment of schizophrenia and manic and mixed episodes of bipolar I disorder. Klinik Psikofarmakoloji Bulteni-Bulletin of Clinical Psychopharmacology 2013;23(1):99-106.

Pazvantoglu O, Algul A, Ateş M A, Sarisoy G, Ebrinc S, Basoglu C, Cetin M. Metacognitive functions in obsessive compulsive disorder in a Turkish clinical population: the relationship between symptom types and metacognition subdimensions. Bulletin of Clical Psychopharmacology 2013; 23: 65-71.

Aydin N, Cetin M, Kurt E, Savas H, Acikel C, Kilic S, Basoglu C, Turkcapar H. A report by Turkish Association for Psychopharmacology on the psychotropic drug usage in Turkey and medical, ethical and economical consequences of current applications. Klinik Psikofarmakoloji Bulteni-Bulletin of Clinical Psychopharmacology 2013;23(4):390-402.

Cetin M, Aricioglu F. Unmet needs in psychiatry and emerging novel pharmacological agents. Klinik Psikofarmakoloji Bulteni-Bulletin of Clinical Psychopharmacology 2013;23(3):199-204

Greb C, Cetin M, Gries T, Kaufmann M, Berg DC. Design for manufacture of composites-demaco. International SAMPE Technical Conference 2013;1460-1473.

Cetin M. Clozaphobia: Fear of Prescribers of Clozapine for Treatment of Schizophrenia. Klinik Psikofarmakoloji Bülteni – Bulletin of Clinical Psychopharmacology 2014;24(4):295-301.

Cetin M, Aricioglu F. Sights For Sore Eyes and Disappointments in Psychopharmacology. Klinik Psikofarmakoloji Bülteni – Bulletin of Clinical Psychopharmacology 2014;24(2):111-4.

Cetin M. Polypharmacy is a need in psychiatric practice. Klinik Psikofarmakoloji Bülteni – Bulletin of Clinical Psychopharmacology 2014;24:S49.

Cetin M. A Serious Risk: Excessive and inappropriate antipsychotic prescribing. Klinik Psikofarmakoloji Bülteni – Bulletin of Clinical Psychopharmacology 2014;24(1):1-4.

Cetin M, Kilic S. Number needed to treat: an important measure for the correct assessment of clinical significance. Klinik Psikofarmakoloji Bülteni – Bulletin of Clinical Psychopharmacology 2015;25(1):1-3.

Cetin M. Treatment of schizophrenia: past, present and future. Klinik Psikofarmakoloji Bulteni-Bulletin of Clinical Psychopharmacology 2015;25(2):95-9.
.

Hizli-Sayar G, Cetin M. Over-the-counter purchase and off-label use of modafinil. Klinik Psikofarmakoloji Bulteni – Bulletin of Clinical Psychopharmacology 2015;25(3):312-3.

.

Ates A, Oner I, Tutuncu R, Basoglu C, Cetin M, Balibey H, Algul A, Ebrinc S. Relationship Between Plasma Levels of Prolactin and the Severity of Negative Symptoms in Patients with Schizophrenia. Klinik Psikofarmakoloji Bulteni – Bulletin of Clinical Psychopharmacology 2015;25(1):27-37.

Hizli Sayar G, Cetin M. A Futuristic Approach to Psychiatric Diagnosis. Klinik Psikofarmakoloji Bulteni – Bulletin of Clinical Psychopharmacology 2015;25(4):321-5.

Mifflin K, Benson C, Kerr B, Aricioglu F, Cetin M, Dursun S. Baker G. Involvement of Neuroactive Steroids in Pain, Depression and Anxiety. Finn DP, Leonard BE (eds): Pain in Psychiatric Disorders. Mod Trends Pharmacopsychiatry. Basel, Karger, 2015, vol 30, pp 94-102. Tutuncu RK, Selim B, Cengiz A, Mehmet AA, Ayhan B, Hakan G, Huseyin S, Umit BO, Cem ES, Cetin M. Turkish Psychopathy Checklist—Revised. 2015.

Cetin M, Hizli Sayar G. Risk Evaluation and Mitigation Strategy for Clozapine. Klinik Psikofarmakoloji Bulteni – Bulletin of Clinical Psychopharmacology 2016;26(1):1-6.

Hizli-Sayar G, Cetin M. Psychobiotics: the potential therapeutic promise of microbes in psychiatry. Klinik Psikofarmakoloji Bulteni – Bulletin of Clinical Psychopharmacology 2016;26(2):93-102.

Sahin C, Dursun S, Cetin M, Aricioglu F. The neuroinflammation perspective of depression: reuniting the outstanding mechanisms of the pathophysiology. Klinik Psikofarmakoloji Bulteni – Bulletin of Clinical Psychopharmacology 2016;26(2):196-206.

Kose S, Cetin M. ß-adrenergic Receptor Blocker Use for Traumatic Memory Reconsolidation in Posttraumatic Stress Disorder. Klinik Psikofarmakoloji Bulteni – Bulletin of Clinical Psychopharmacology 2016;26(3):215-22.

Cetin M, Kose S. Klozafobik tutumlara karşı güncellenmiş klozapin ile tedavi kılavuzu. Journal of Mood Disorders (JMOOD) 2016;6(4):242-55.

Thomas R, Cetin M, Baker GB, Dursun SM. Comment on FDA’s breakthrough therapy designation of intranasal esketamine for the treatment of major depressive disorder with imminent risk of suicide. Klinik Psikofarmakoloji Bulteni – Bulletin of Clinical Psychopharmacology 2016;26(4):329-31.

Pan E, Ates MA, Algul A, Aytekin A, Basoglu C, Ebrinc S, Cetin M, Kose S. Fractional anisotropic changes of corpus callosum associated with antipsychotic treatment in first-episode antipsychotic drug-naive patients with schizophrenia. Klinik Psikofarmakoloji Bulteni – Bulletin of Clinical Psychopharmacology 2016;26(4):332-41.

Aricioglu F, Sahin-Ozkartal C, Unal G, Dursun S, Cetin M, Muller N. Neuroinflammation in schizophrenia: a critical review and the future Klinik Psikofarmakoloji Bulteni – Bulletin of Clinical Psychopharmacology 2016;26(4):429-37.

Yilmaz O, Ates MA, Semiz UB, Tutuncu R, Bez Y, Algul A, Balibey H, Basoglu C, Ebrinc S, Cetin M. Childhood traumas in patients with bipolar disorder:association with alexithymia and dissociative experiences. Anatolian Journal of Psychiatry 2016; 17(3):188-195.

Kraus M, Cetin M, Aricioglu F. The microbiota and gut-brain axis. Journal of Mood Disorders (JMOOD) 2016;6(3):172-9.

Akin E, Cetin M, Kose S. An update on borderline personality disorder: life in the fast lane. Journal of Mood Disorders (JMOOD) 2017;7(1):65-72.

Kose S, Cetin M. The Research Domain Criteria framework: transitioning from dimensional systems to integrating neuroscience and psychopathology. Psychiatry and Clinical Psychopharmacology 2017;27(1):1-5.

Kose S, Cetin M. Ketamine and electroconvulsive therapy pairing in depression and mood disorders. Psychiatry and Clinical Psychopharmacology 2017;27(2):103-105.

Kose S, Akin E, Cetin M. Adverse drug reactions and causality: the Turkish version of Naranjo Adverse Drug Reactions Probability Scale. Psychiatry and Clinical Psychopharmacology 2017;27(2):210-211.

Kose S, Cetin M. Ketamine and rapastinel: NMDA receptor modulators in the rapid treatment of obsessive-compulsive disorder. Psychiatry and Clinical Psychopharmacology 2017;27(3):213-214.

Kose S, Cetin M. Brexanolone: an allosteric modulator of GABA-A receptors in the rapid treatment of postpartum depression. Psychiatry and Clinical Psychopharmacology. 2017;27(4):326-328.
Samet Kose & Mesut Cetin (2018) Cannabis-associated psychotic symptoms and neurocognitive effects at high risk psychosis patients, Psychiatry and Clinical Psychopharmacology, 28:1, 1-3,
Samet Kose & Mesut Cetin (2018) Triple reuptake inhibitors (TRIs): do they promise us a rose garden?, Psychiatry and Clinical Psychopharmacology, 28:2, 119-122,

KİTAP EDİTÖRLÜKLERİ ve KİTAP BÖLÜMLERİ

1. Mesut Çetin. Psikomatik Perspektiften Allerjik Hastalıklar ve Bronşiyal Astma. Allerjik Hastalıklar ve Bronşiyal Astma/1. Cilt. Bilmedya Grup, İstanbul, 2004 Cilt I. sayfa:291-3232. Mesut Çetin, Bölüm 1.Psikiyatrinin Kısa Tarihi, Araştırma ve Klinik Uygulamada Biyolojik Psikiyatri,ŞİZOFRENİ. Editörler M.Emin Ceylan, Mesut Çetin, 3. baskı; Küre İletişim Grubu, İstanbul,2005, sayfa:1-65.

3. Mesut Çetin, M.Emin Ceylan, Bölüm 2.Genel Bilgiler, Araştırma ve Klinik Uygulamada Biyolojik Psikiyatri,ŞİZOFRENİ. Editörler M.Emin Ceylan, Mesut Çetin, 3. baskı; Küre İletişim Grubu, İstanbul,2005, sayfa:66-99.

4. Tarhan,N., Çetin,M.: Depresyonda Biyolojik Göstergeler,Depresyon Monografları Serisi,.(Editor) Köroğlu E. Medikomat.Hekimler Yayın Birliğli,Ankara, 1993 Vol.4,sayfa:175-200.

5. Çetin M. Tarhan N.: Depresyonun Psikoendokrinolojisi, Depresyon Monografları Serisi.,. (Editor) Köroğlu E. Medikomat.Hekimler Yayın Birliğli,Ankara, 1993 Vol.6,sayfa:253-281.

6. Klinik Psikofarmakolojide Yenilikler-I “Ulusal Sempozyum” Kitabı, Editörler: Tarhan,N, Ceylan,ME, Çetin M, İstanbul,1991.

7. Çetin,M., Evren C: Atipik Nöroleptikler. Klinik Psikofarmakolojide Yenilikler-IV “Uluslararası Katılımlı Sempozyum” Kitabı, Editörler: Çetin M, Ağargün MY, Ebrinç S. Nobel Tıp Kitabevleri,İstanbul,1998, s:92-135.

8. Çetin M. Antisosyal kişilik bozukluğunda komorbit hastalıklar, ayırıcı tanı ve idare. (Editör: Erden C.) Antisosyal Kişilik Bozukluğu , Çorlu, 2002, s:17-29.

9. Çetin M. Alerji Etyolojisinde Psikolojik Faktörlerin Rolü. (Editör: Aydilek R.): Alerjik Hastalıklar ve Bronşial Astma, İstanbul, 1998, Cilt 1, sayfa:277-300.

10. Mesut Çetin, Bölüm 1. Psikiyatrini kısa tarihi, Araştırma ve Klinik Uygulamada Biyolojik Psikiyatri,ŞİZOFRENİ. Editörler M.Emin Ceylan, Mesut Çetin, 3. baskı; Küre İletişim Grubu, İstanbul,2005, sayfa:1-8311. Mesut Çetin, M.Emin Ceylan Bölüm 2. Genel Bilgiler, Araştırma ve Klinik Uygulamada Biyolojik Psikiyatri,ŞİZOFRENİ. Editörler M.Emin Ceylan, Mesut Çetin, 3. baskı; Küre İletişim Grubu, İstanbul,2005, sayfa:83-12512. Mesut Çetin, M.Emin Ceylan Bölüm 3. Şizofrenide Temel Psikofarmakoloji, Araştırma ve Klinik Uygulamada Biyolojik Psikiyatri,ŞİZOFRENİ. Editörler M.Emin Ceylan, Mesut Çetin, 3. baskı; Küre İletişim Grubu, İstanbul,2005, sayfa:125-14713. Mesut Çetin Bölüm 32. Psikiyatride hasta hakları ve etik açısından ilaç uygulaması, Araştırma ve Klinik Uygulamada Biyolojik Psikiyatri,ŞİZOFRENİ. Editörler M.Emin Ceylan, Mesut Çetin, 3. baskı; Küre İletişim Grubu, İstanbul,2005, sayfa:839-84914. Mesut Çetin, Bölüm 33.Psikofarmakoterapinin genel ilkeleri,hasta hakları ve etik. Araştırma ve Klinik Uygulamada Biyolojik Psikiyatri,ŞİZOFRENİ. Editörler M.Emin Ceylan, Mesut Çetin, 3. baskı; Küre İletişim Grubu, İstanbul, 2005, sayfa:849-861.

15. Mesut Çetin, Bölüm 34. Antipsikotiklerin etki ve yan etkilerinin temelleri. Araştırma veKlinik Uygulamada Biyolojik Psikiyatri,ŞİZOFRENİ. Editörler M.Emin Ceylan, Mesut Çetin, 3. baskı; Küre İletişim Grubu, İstanbul,2005, sayfa:861-88116. Mesut Çetin, M.Emin Ceylan, Bölüm 35.Tipik antipsikotikler ve antipsikotik tedavisinin klinik ilkeleri. Araştırma ve Klinik Uygulamada Biyolojik Psikiyatri,ŞİZOFRENİ. Editörler M.Emin Ceylan, Mesut Çetin, 3. baskı; Küre İletişim Grubu, İstanbul,2005, sayfa: 991-93717. Mesut Çetin, Bölüm 36. Yeni antipsikotikler- I. Araştırma ve Klinik Uygulamada Biyolojik Psikiyatri,ŞİZOFRENİ. Editörler M.Emin Ceylan, Mesut Çetin, 3. baskı; Küre İletişim Grubu, İstanbul,2005, sayfa: 937-997.

18. Mesut Çetin, Bölüm 37. Yeni antipsikotikler- II. Araştırma ve Klinik Uygulamada Biyolojik Psikiyatri,ŞİZOFRENİ. Editörler M.Emin Ceylan, Mesut Çetin, 3. baskı; Küre İletişim Grubu, İstanbul,2005, sayfa:997-1019.

19. Mesut Çetin, Bölüm 38. Klinik uygulamada yeni antipsikotikler ve yan etkileri. Araştırma ve Klinik Uygulamada Biyolojik Psikiyatri,ŞİZOFRENİ. Editörler M.Emin Ceylan, Mesut Çetin, 3. baskı; Küre İletişim Grubu, İstanbul,2005, sayfa:1019-1067.

20. Mesut Çetin, Bölüm 39. Yeni antipsikotikler ile ilgili çeşitlikonular. Araştırma ve Klinik Uygulamada Biyolojik Psikiyatri, ŞİZOFRENİ. Editörler M.Emin Ceylan, Mesut Çetin, 3. baskı; Küre İletişim Grubu, İstanbul,2005, sayfa: Mesut Çetin, Bölüm 53. Özel durumlarda ilaç kullanımı. Araştırma ve Klinik Uygulamada Biyolojik Psikiyatri, ŞİZOFRENİ. Editörler M.Emin Ceylan, Mesut Çetin, 3. baskı; Küre İletişim Grubu, İstanbul,2005, sayfa: Mesut Çetin, M.Emin Ceylan, Bölüm 55. Şizofrenide kullanılan testler. Araştırma ve Klinik Uygulamada Biyolojik Psikiyatri, ŞİZOFRENİ. Editörler M.Emin Ceylan, Mesut Çetin, 3. baskı; Küre İletişim Grubu, İstanbul,2005, sayfa: 1178-1271.

23. M. Emin Ceylan, Mesut Çetin, Bölüm 56. Şizofrenide kullanılan testler Araştırma ve Klinik Uygulamada Biyolojik Psikiyatri, ŞİZOFRENİ. Editörler 3. baskı; Küre İletişim Grubu, İstanbul,2005, M. Emin Ceylan, Mesut Çetin, Araştırma ve Klinik Uygulamada Biyolojik Psikiyatri, ŞİZOFRENİ. Editörler 3. baskı; Küre İletişim Grubu, İstanbul,200525. Mesut Çetin, Psikiyatride Etik, Klinik Psikiyatri, Kaplan Sadock’s KLİNİK PSİKİYATRİ EL KİTABI H. Aydın, A.Bozkurt (çev editörleri), Güneş Kitabevi,Ankara,2005, s.615-61926. Mesut Çetin, Servet Ebrinç, (editörler) 1.Ulusal Psikofarmakoloji Kongresi 14- 17 Aralık 2005, İstanbul ,Bildiri Özet Kitabı İstanbul,200527. Mesut Çetin, Servet Ebrinç, (editörler) 2.Ulusal Psikofarmakoloji Kongresi Bildiri Özet Kitabı, İstanbul 2007


ÇEVİRİLER
1. Mesut Çetin, (çeviri editörü) Obezitenin Bilişşsel Davranışçı Tedavisi, Küre Yayıncılık, İstanbul 2007


ÖDÜLLER
• Ebrinç S., Başoğlu C., Yılmaz V., Çetin M., Narin Y., “Majör depresyonlu hastalarda SPECT uygulaması: Geç parsiyel uyku deprivasyonu ve antidepresif ilaç tedavisinin bölgesel serebral kan perfüzyonuna etkilerinin araştırılması”. 3. Ulusal Biyolojik Psikiyatri Kongresi, 18-21 Haziran, Dedeman Otel, Kapadokya, Nevşehir, 2001, Kongre Poster Ödülü.

• Çetin M., Başoğlu C., Öner Ö., Ebrinç S., Semiz Ü.B., Kandilcioğlu H., “Kronik şizofrenili hastalarda 1H MRSI ile saptanan sağ talamik ve temporal korteks metabolik farklılıklarının psikotrop ilaç kullanmamış ilk atak psikotik bozukluklu hastalar ve sağlıklı kontrollerle karşılaştırılması” 40. Ulusal Psikiyatri Kongresi, 28 Eylül-3 Ekim 2004, Kuşadası, Türk Psikiyatri Derneği Poster Ödülü.

• Başoğlu C., Çetin M., Öner Ö., Ebrinç S., Semiz ÜB., Kandilcioğlu H, Şilit E, Kızılkaya E., “İlaç kullanmamış ve kronik psikotik hastalarda sağ talamus ve temporal korteks metabolit seviyelerinin karşılaştırılması” Türk Psikiyatri Dergisi Araştırma Ödülü, 2006.

• Pan E, Algül A, Başoğlu C, Ebrinç S, Çetin M., Aytekin A, Köse S. “Antipsikotik ilaç tedavisi almamış ilk atak şizofreni hastalarında korpus kallozumda azalmış fraksiyonel anizotropi”. Sözel Bildiri Birincilik Ödülü, 46ncı Ulusal Psikiyatri Kongresi, İzmir, 5-9 Ekim, 2010.

• Algül A, Şen H, Ateş MA, Yen T, Durmaz O, Özkan S, Başoğlu C, Semiz ÜB, Ebrinç S, Dağlı G, Çetin M. “Elektrokonvülzif tedavide propofol ile propofol remifentanil kombinasyonun nöbet süresi ve hemodinami üzerine etkisi” Poster bildiri İkincilik Ödülü, 4ncü Ulusal Psikofarmakoloji Kongresi, Antalya, 23-27 Kasım 2011.